Adherium Limited (ASX:ADR)
0.0770
+0.0020 (2.67%)
Oct 9, 2026, 3:03 PM AEST
Adherium Market Cap
Adherium has a market cap or net worth of 4.23 million as of October 9, 2026. It is the 46,882nd most valuable company in the world and the 1,578th biggest in Australia. Its market cap has decreased by 54.63% in one year.
Market Cap
4.23M
Enterprise Value
5.20M
Revenue
2.10M
Global Rank
Country Rank
#1,578 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 26, 2015, Adherium's market cap has decreased from 732.84M to 4.23M, a decrease of -99.42%. That is a compound annual growth rate of -37.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 4.23M | -72.43% |
| Dec 31, 2025 | 15.33M | 44.33% |
| Dec 31, 2024 | 10.62M | -43.13% |
| Dec 29, 2023 | 18.67M | -6.25% |
| Dec 29, 2022 | 19.92M | -17.73% |
| Dec 31, 2021 | 24.21M | 27.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 43.19M |
| Nova Eye Medical | 38.46M |
| Control Bionics | 34.21M |
| CleanSpace Holdings | 33.33M |
| OncoSil Medical | 26.24M |
| ImpediMed | 21.97M |
| Atomo Diagnostics | 16.24M |
| Memphasys | 15.44M |